This scoring system includes age, tumor grade, LGG diagnosis type, tumor type (primary and recurrence), IDH1 (R132) mutation status, and the risk score of m6A regulator-related AS events (Figure 8F). This evidence concerns the gene IDH1 and neoplasm.